ArticleBreast cancer research : BCR2026
Toxicity profiles of proton and photon radiotherapy in postoperative breast cancer: a 10-year real-world cohort study.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProton therapy, with its superior dose distribution, has emerged as a promising radiotherapy (RT) technique. This study evaluates the clinical benefits of proton therapy in reducing treatment-related toxicities in breast cancer patients undergoing radiotherapy.
methodsA retrospective analysis was performed using the Chang Gung Research Database, identifying 8189 breast cancer patients treated with adjuvant radiotherapy from 2012 to 2022. Patients received either intensity-modulated proton therapy (IMPT, n = 501) or photon-based IMRT/VMAT (n = 7688). Propensity score weighting was applied to adjust for baseline differences. The clinical outcomes photon and proton therapy were investigated, with a particular focus on radiation-induced toxicities including dermatitis, pulmonary changes, and cardiac events. In addition, N-terminal pro-brain natriuretic peptide (NT-proBNP), a biomarker of cardiac stress, was prospectively assessed in a subset of patients to assess subclinical cardiac injury between 2023 and 2024.
resultsCompared with photon therapy, proton therapy significantly reduced the incidence of radiographic pulmonary changes and subclinical cardiac biomarker elevations, while maintaining comparable loco-regional control and overall survival. Proton therapy significantly reduced the incidence of radiographic pulmonary changes (5.8% vs. 10.0%, p = 0.02; HR: 0.64, 95% CI 0.44–0.93) and grade 2 radiation dermatitis (13.4% vs. 20.9%, p < 0.001), though grade ≥ 1 skin toxicity was more common with IMPT (82% vs. 57.1%). Among left-sided patients, photon RT resulted in significantly greater NT-proBNP elevation post-treatment compared to proton therapy (mean ratio: 1.16 vs. 0.95, p = 0.0099), suggesting more subclinical cardiac stress. However, no significant difference in clinically evident cardiac events was noted between the groups during the follow-up period.
conclusionsProton therapy is associated with reduced radiation-induced pulmonary toxicity and moderate dermatitis, while achieving comparable oncologic outcomes to photon therapy. The lower NT-proBNP elevation suggests potential cardiac sparing, although longer follow-up is needed to confirm clinically meaningful cardiac benefits. These findings highlight the potential role of proton therapy in mitigating treatment-related toxicities in breast cancer patients at elevated risk for cardiopulmonary complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.